Theodore S. Hong, MD

Radiation Oncologist
Massachusetts General Hospital Cancer Center; and Harvard Medical School
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• eP816 - A randomized phase-II trial testing triplet versus doublet chemotherapy to achieve complete response in patients with locally advanced rectal cancer

  Monday, June 3, 2024
  11:00 AM – 11:05 AM ET, USA

• eP826 - NRG-GI008: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE - NORTH AMERICA)

  Monday, June 3, 2024
  1:57 PM – 2:02 PM ET, USA

• LB802 - Results Of ctDNA As A Predictive Biomarker In Adjuvant Chemotherapy In Stage II Colon Cancer: NRG-GI005 (COBRA) Phase II/III study

  Monday, June 3, 2024
  3:55 PM – 4:01 PM ET, USA